News and Announcements
SUDA Appendix 4C For First Quarter FY2017
- Published November 01, 2016 9:57AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31 October 2016, ASX Announcement
SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated Group for the first quarter of FY2017. Receipts from customers for the period were $1.6 million, an increase of 25% from the first quarter of FY2016.
The Company reduced its net operating cash loss to $0.25 million in the first quarter compared to $0.61 million in the previous corresponding period of FY2016. Net cash used in investing activities was $0.29 million for the quarter. The cash position as at 30 September 2016 was $1.9 million.
To view the full announcement, please click on the button below.